Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasia
- 1 January 2008
- journal article
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 47 (1), 173-182
- https://doi.org/10.1016/j.jvs.2007.09.005
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2007 UpdateCirculation, 2007
- Heparin Binding Nanostructures to Promote Growth of Blood VesselsNano Letters, 2006
- Presentation of RGDS Epitopes on Self-Assembled Nanofibers of Branched Peptide AmphiphilesBiomacromolecules, 2006
- Selective Differentiation of Neural Progenitor Cells by High-Epitope Density NanofibersScience, 2004
- Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese populationThe American Journal of Cardiology, 2001
- The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplastyCardiovascular Research, 1995
- Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.JCI Insight, 1994
- NITRIC OXIDE: A Physiologic Messenger MoleculeAnnual Review of Biochemistry, 1994
- L-Arginine Inhibits Balloon Catheter-Induced Intimal HyperplasiaBiochemical and Biophysical Research Communications, 1993
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.JCI Insight, 1989